Tasman Metals Takes a Dive Midday After Ending Merger Negotiations

0
Tasman Metals Takes a Dive Midday After Ending Merger Negotiations

Galectin Therapeutics Inc. (NASDAQ:GALT), FireEye Inc (NASDAQ:FEYE) and Hansen Medical, Inc. (NASDAQ:HNSN) 6.06% are this Tuesday’s top gainers midday. The losers are Tasman Metals Ltd (NYSEMKT:TAS), International Tower Hill Mines Ltd (NYSEMKT:THM) and Intrexon Corp (NYSE:XON).

Drug Developer Galectin Surges

Surging +6.85%, today’s top midday gainer is Galectin Therapeutics Inc. (NASDAQ:GALT). The drug developer missed the mark with its results release last Tuesday but is apparently making a comeback. Billionaire George Soros initiated a position in the company in Q1.

This mining and metals fund is having a strong year so far

Cubic Corporation Chris Hohn favorite hedge fundsThe Delbrook Resources Opportunities Master Fund was up 9.2% for May, bringing its year-to-date return to 33%. Q1 2021 hedge fund letters, conferences and more Dellbrook is an equity long/ short fund that focuses exclusively on the metals and mining sector. It invests mainly in public companies focused on precious, base, energy and industrial metals Read More


Network security company FireEye Inc (NASDAQ:FEYE) jumped +6.36% ahead of its lock-up expiration tomorrow, with which 92 million shares are expected to become available. Tiger Global has maintained a position in the company across two quarters.

The share price of Hansen Medical, Inc. (NASDAQ:HNSN), another Soros Q1 buy, surged +6.06% midday. The firm appointed a new CEO at the start of the month and has also experienced a handful of insider purchases. Today, Cowen and Company lowered its target price to $2.50.

Tasman Metals Dips

Tasman Metals Ltd (NYSEMKT:TAS) dipped -8.65% today after agreeing to end merger negotiations with Flinders Resources Limited. George Soros has maintained a 1.6-million share position in the company across several quarters.

Down -6.25% midday today, International Tower Hill Mines Ltd (NYSEMKT:THM) takes the second spot on today’s list of losers. The John Paulsonpick is still up a solid +51.22% in 2014.

Intrexon Corp (NYSE:XON) slipped -6.12%. In the portfolios of billionaires investors David Einhorn and Daniel Loeb, the biotech company experienced a share price surge late last week but has struggled this year and is down -29.24% YTD.

 

No posts to display